Serial Changes of Cytokines in Children with Cerebral Palsy Who Received Intravenous Granulocyte-colony Stimulating Factor Followed by Autologous Mobilized Peripheral Blood Mononuclear Cells

Journal of Korean Medical Science
Hani KohYoung-Ho Lee

Abstract

This study was performed to assess serial cytokine changes and their clinical impact in children with cerebral palsy (CP) who received granulocyte-colony stimulating factor (G-CSF) followed by infusion of autologous mobilized peripheral blood mononuclear cells (mPBMCs). Peripheral blood (PB) samples were collected from 16 CP children at enrollment, and 1 month and 7 months after G-CSF infusion as well as at the end of the study. Cytokine levels were measured by enzyme-linked immunosorbent assays with plasma samples. There were no significant differences in cytokine levels between the mPBMC and placebo groups over 6 months. However, when clinical responders and non-responders were compared, interleukin (IL)-6 (P = 0.050) as well as G-CSF (P = 0.010) were higher in the responders than the non-responders at 1 month, while brain-derived neurotrophic factor (BDNF) (P = 0.030) and insulin-like growth factor (IGF)-1 (P = 0.001) were lower. In addition, BDNF was higher at baseline in the responders than the non-responders (P = 0.030). The changes of G-CSF itself, as well as G-CSF-induced cytokines such as IL-6, may be associated with the clinical improvement of neurologic functions. The G-CSF-induced changes of IL-6, BDNF and IGF-1, an...Continue Reading

References

Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L R WilliamsF H Gage
Apr 1, 1986·Acta Physiologica Scandinavica·H A HanssonG Lundborg
Apr 3, 2002·Psychiatry Research·Félicien KaregeJean-Michel Aubry
Nov 9, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Eric D RabinovskyRobert J Schwartz
Dec 9, 2004·Neurobiology of Aging·Marek LommatzschJohann Christian Virchow
May 17, 2005·Journal of the Neurological Sciences·Dan FrenkelHoward L Weiner
Jul 12, 2005·The Journal of Clinical Investigation·Armin SchneiderWolf-Rüdiger Schäbitz
Oct 15, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yuichi OhkiAkimichi Ohsaka
Apr 19, 2006·Journal of Cellular Biochemistry·Arnold I Caplan, James E Dennis
Apr 12, 2012·Brain : a Journal of Neurology·Karen GertzMatthias Endres

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

SAS

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.